Managers / Q2 2020 · view latest →
Mohican Financial Management, LLC
CIK 0001367663 · 21 RIVER RD, SUITE 2100, WILTON, CT, 06897 · 203-423-8029
Summary
Mohican Financial Management, LLC reported $55M in U.S.-listed holdings across 40 positions for Q2 2020.
Its largest position, Fti Consulting, represents 5.9% of the portfolio.
Compared with Q1 2020, the fund opened 9 new positions and exited 16.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- US DOMESTIC · 94.2% · $52M
- GLOBAL · 5.8% · $3M
Quarter-over-Quarter Changes full breakdown →
vs Q1 2020 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| SSR MNG INC | NEW | +1.91M | 1.91M | +$3M | $3M |
| SPIRIT AIRLS INC | NEW | +1.00M | 1.00M | +$1M | $1M |
| LIVEPERSON INC | NEW | +1.00M | 1.00M | +$1M | $1M |
| ZILLOW GROUP INC | NEW | +1.00M | 1.00M | +$1M | $1M |
| AMERICAN AIRLS GROUP INC | NEW | +1.00M | 1.00M | +$939,000 | $939,000 |
| PENN NATL GAMING INC | NEW | +500.0K | 500.0K | +$751,000 | $751,000 |
| XERIS PHARMACEUTICALS INC | NEW | +500.0K | 500.0K | +$494,000 | $494,000 |
| REALPAGE INC | NEW | +400.0K | 400.0K | +$433,000 | $433,000 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2020
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | FTI CONSULTING INC | NOTE 2.000% 8/1 | 5.86% | $3M | 2.55M |
| 2 | SPLUNK INC | NOTE 1.125% 9/1 | 5.30% | $3M | 2.00M |
| 3 | PERFICIENT INC | NOTE 2.375% 9/1 | 5.20% | $3M | 2.50M |
| 4 | EXACT SCIENCES CORP | NOTE 1.000% 1/1 | 5.09% | $3M | 2.06M |
| 5 | KBR INC | NOTE 2.500%11/0 | 5.07% | $3M | 2.50M |
| 6 | MESA LABS INC | NOTE 1.375% 8/1 | 4.84% | $3M | 2.70M |
| 7 | SSR MNG INC | NOTE 2.500% 4/0 | 4.73% | $3M | 1.91M |
| 8 | VOCERA COMMUNICATIONS INC | NOTE 1.500% 5/1 | 4.40% | $2M | 2.50M |
| 9 | TWITTER INC | NOTE 1.000% 9/1 · NOTE 0.250% 6/1 | 4.14% | $2M | 2.36M |
| 10 | CONMED CORP | NOTE 2.625% 2/0 | 3.79% | $2M | 2.00M |
| 11 | FIREEYE INC | NOTE 0.875% 6/0 · NOTE 1.625% 6/0 | 3.75% | $2M | 2.25M |
| 12 | REPLIGEN CORP | NOTE 0.375% 7/1 | 3.44% | $2M | 1.51M |
| 13 | TTM TECHNOLOGIES INC | NOTE 1.750%12/1 | 3.38% | $2M | 1.50M |
| 14 | ENVESTNET INC | NOTE 1.750% 6/0 | 3.36% | $2M | 1.52M |
| 15 | KAMAN CORP | NOTE 3.250% 5/0 | 3.33% | $2M | 1.94M |
| 16 | GUIDEWIRE SOFTWARE INC | NOTE 1.250% 3/1 | 3.15% | $2M | 1.50M |
| 17 | INFINERA CORP | NOTE 2.125% 9/0 | 3.09% | $2M | 2.00M |
| 18 | Q2 HLDGS INC | NOTE 0.750% 2/1 | 2.84% | $2M | 1.00M |
| 19 | SPIRIT AIRLS INC | NOTE 4.750% 5/1 | 2.70% | $1M | 1.00M |
| 20 | LIVEPERSON INC | NOTE 0.750% 3/0 | 2.24% | $1M | 1.00M |
| 21 | II-VI INC | NOTE 0.250% 9/0 | 2.15% | $1M | 1.00M |
| 22 | ZILLOW GROUP INC | NOTE 2.750% 5/1 | 2.11% | $1M | 1.00M |
| 23 | KNOWLES CORP | NOTE 3.250%11/0 | 1.94% | $1M | 1.00M |
| 24 | ENCORE CAP GROUP INC | NOTE 2.875% 3/1 · NOTE 3.000% 7/0 | 1.88% | $1M | 1.06M |
| 25 | AMERICAN AIRLS GROUP INC | NOTE 6.500% 7/0 | 1.70% | $939,000 | 1.00M |
| 26 | HELIX ENERGY SOLUTIONS GRP I | NOTE 4.250% 5/0 · NOTE 4.125% 9/1 | 1.50% | $828,000 | 1.00M |
| 27 | RETROPHIN INC | NOTE 2.500% 9/1 | 1.48% | $819,000 | 1.00M |
| 28 | PENN NATL GAMING INC | NOTE 2.750% 5/1 | 1.36% | $751,000 | 500.0K |
| 29 | FLEXION THERAPEUTICS INC | NOTE 3.375% 5/0 | 1.14% | $633,000 | 750.0K |
| 30 | EVOLENT HEALTH INC | NOTE 1.500%10/1 | 1.08% | $598,000 | 1.00M |
| 31 | XERIS PHARMACEUTICALS INC | NOTE 5.000% 7/1 | 0.89% | $494,000 | 500.0K |
| 32 | THERAVANCE BIOPHARMA INC | NOTE 3.250%11/0 | 0.87% | $482,000 | 500.0K |
| 33 | NEWPARK RES INC | NOTE 4.000%12/0 | 0.79% | $438,000 | 500.0K |
| 34 | REALPAGE INC | NOTE 1.500% 5/1 | 0.78% | $433,000 | 400.0K |
| 35 | TIMKENSTEEL CORP | NOTE 6.000% 6/0 | 0.62% | $345,000 | 425.0K |
| 36 | GLOBAL EAGLE ENTMT INC | NOTE 2.750% 2/1 | 0.03% | $15,000 | 500.0K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q2 2021 | $256M | 70 | Jul 28, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $154M | 51 | Apr 29, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $98M | 46 | Jan 14, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $80M | 47 | Oct 20, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $55M | 40 | Jul 20, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $70M | 47 | Apr 29, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $64M | 40 | Jan 28, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $65M | 46 | Oct 25, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $68M | 49 | Jul 11, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $31M | 31 | Apr 23, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $24M | 30 | Jan 29, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.